USPTO serial 87628754
ZABBIO
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- LAMONT, JOHN CHRISTOPHER
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ZABBIO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
San Diego, CA
San Diego, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Paul Nardulli
PAUL NARDULLI OPTIMA LAW GROUP4275 EXECUTIVE SQUARE, SUITE 200LA JOLLA, CA 92037UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic reagents for scientific or research use; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; Reagents for chemical analysis, other than for medical or veterinary purposes; Reagents for research purposes; Reagents for scientific or medical research use; Reagents for testing the sterility of pharmaceuticals and injectable solutions; Reagents for use in scientific apparatus for chemical or biological analysis; Reagents for use in infectious disease research | ACTIVE | — |
| 010 | Contraceptive apparatus; Intra uterine contraceptive devices; Contraceptive vaginal rings; Medical apparatus for introducing pharmaceutical preparations into the human body | ACTIVE | — |
| 042 | Pharmaceutical research and development; research and development of pharmaceutical preparations for the treatment and prevention of cardiovascular diseases and disorders, central nervous system and neurological diseases and disorders, viral and infectious diseases, cancer, urological diseases and disorders, gastrointestinal diseases and disorders, musculoskeletal diseases and disorders, migraines and headaches, pain, hypertension, inflammation and inflammatory diseases and disorders, metabolic diseases and disorders, respiratory and infectious diseases and disorders, immunological, bacterial, viral and fungal diseases and disorders, psychiatric diseases and disorders, asthma, allergies, diabetes, obesity, stroke, erectile and sexual dysfunction, sexually transmitted infections including, but not limited to, HIV, HPV, and herpes and hemolytic diseases and disorders; research and development of pharmaceutical preparations, namely, cholesterol preparations, osteoporosis preparations, oncological preparations, dermatological preparations, urological preparations, contraceptives, ophthalmologic preparations, tissue and skin repair preparations and gynecological preparations; research and development of drug delivery devices; medical and scientific research, namely, conducting clinical trials for others; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Pharmaceutical research and development services; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; Pharmaceutical research and development in relation to infectious disease prevention and therapy | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ZabBio, Inc.
- Other trademarks owned by ZabBio, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named ZABBIO
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 29, 2020 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 29, 2020 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 14, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED | — |
| Nov 12, 2019 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 12, 2019 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 12, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 28, 2019 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 2, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 13, 2019 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 27, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 26, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 26, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 26, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 31, 2019 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 31, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 11, 2019 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jan 10, 2019 | ALIE | ASSIGNED TO LIE | — |
| May 17, 2018 | CNSL | LETTER OF SUSPENSION MAILED | — |
| May 17, 2018 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 15, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 14, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 14, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 8, 2018 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 8, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 8, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 5, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 3, 2017 | NWAP | NEW APPLICATION ENTERED | — |